NCT05386979

Brief Summary

Comparative study to explore the effect of opioid free anesthesia technology in perioperative analgesia management, clarify the effect of naborphine instead of opioids on perioperative analgesia management in morbid obesity patients with moderate and severe OSA, reduce related adverse events, and explore the latest clinical anesthetic drugs.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 10, 2022

Completed
5 days until next milestone

Study Start

First participant enrolled

May 15, 2022

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 24, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2023

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2023

Completed
Last Updated

May 24, 2022

Status Verified

May 1, 2022

Enrollment Period

9 months

First QC Date

May 10, 2022

Last Update Submit

May 22, 2022

Conditions

Keywords

Opioid free anesthesiaBariatric SurgeryERAS

Outcome Measures

Primary Outcomes (1)

  • postoperative NRS score

    A subjective psychometric response scale used to measure distinct behavioral or physiological phenomena based on linear numerical gradient or yes/no alternatives. The Numeric Pain Scale (NRS) pain numerical score(0-10 score, 0: no pain, 10: worst imaginable pain). A pain measurement list about quiet NRS score and cough NRS score at different postoperative time will be used.

    Score from the end of the operation and follow-up at the time point specified in the scoring form for a total of 27 hours.

Secondary Outcomes (11)

  • Dosage of remedial analgesics postoperatively

    It takes about 24 hours.

  • Hemodynamic fluctuation

    From the beginning of the general anesthesia induction to the time leaving PACU, it takes about 4 hours.

  • Ramsay scale

    Score from the end of the operation and follow-up at the time point specified in the scoring form for a total of 27 hours.

  • recovery time

    It will take up to 1 hour or 2 hours.

  • The levels of C-reactive protein (CRP)

    It takes about 24 hours.

  • +6 more secondary outcomes

Study Arms (2)

Opioid anesthesia group

OTHER

Anesthesia induction with propofol 2.5mg/kg, rocuronium bromide 0.6mg/kg, sufentanil 0.3μg/kg, intubation was performed when BIS value reached 40-60. Intraoperative pump injection of propofol 4-12 mg/kg·h and remifentanil 0.2-0.5 μg/kg·min to maintain anesthesia. Ultrasound-guided transversus abdominis plane block (with 0.375% ropivacaine 40ml) will be implemented preoperatively. Ondansetron 8mg and sufentanil 10 μg will be given after surgery. For PCA, sufentanil 2μg/kg + dexmedetomidine 2μg/kg + ondansetron 24mg.

Procedure: Opioid free anesthesia technology

Opioid free anesthesia group

EXPERIMENTAL

Anesthesia induction with propofol 2.5mg/kg, rocuronium bromide 0.6mg/kg, naborphine 0.2mg/kg,esketamine 0.3mg/kg, intubation was performed when BIS value reached 40-60. Intraoperative pump injection of propofol 4-12 mg/kg·h and esketamine 0.3~0.5mg/kg·h. Ultrasound-guided transversus abdominis plane block (with 0.375% ropivacaine 40ml) will be implemented preoperatively. Ondansetron 8mg and naborphine 0.2mg/kg will be given after surgery. For PCA, naborphine 2mg/kg + dexmedetomidine 2μg/kg + ondansetron 24mg.

Procedure: Opioid free anesthesia technology

Interventions

We have adopted a variety of methods to replace the use of opioids in the process of balanced anesthesia.

Opioid anesthesia groupOpioid free anesthesia group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA grade I \~ III;
  • Age from 18 - 65 years old;
  • BMI ≥ 35kg / m2 in patients with OSA to undergo bariatric surgery; (4 provide written informed consent for participation.

You may not qualify if:

  • Age \< 18 years or age \>65 years old;
  • Pregnancy test was positive;
  • Patients with a history of drug abuse or dependence on opioids;
  • Patients with chronic pain or severe heart, lung, liver or nervous system diseases

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yongtao Sun

Jinan, Shandong, 250000, China

Location

Related Publications (1)

  • Guo Y, Chen L, Gao Z, Zhang M, Liu M, Gao X, Liu Y, Zhang X, Guo N, Sun Y, Wang Y. Is esketamine-based opioid-free anesthesia more superior for postoperative analgesia in obstructive sleep apnea patients undergoing bariatric surgery? A study protocol. Front Med (Lausanne). 2022 Nov 15;9:1039042. doi: 10.3389/fmed.2022.1039042. eCollection 2022.

Study Officials

  • Yongtao Sun, doctor

    Qianfoshan Hospital, The First Hospital affiliated of Shandong First Medical University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yongtao Sun, doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

May 10, 2022

First Posted

May 24, 2022

Study Start

May 15, 2022

Primary Completion

January 31, 2023

Study Completion

October 31, 2023

Last Updated

May 24, 2022

Record last verified: 2022-05

Locations